AMGAnna Maria GerettiMD, PhD, FRCPathVideoHIVGlobal HIV Clinical Forum 2016Pharmacological Considerations & Clinical Case Discussion | Anna Maria Geretti, MD, PhD, FRCPathView Video
VideoHIVGlobal HIV Clinical Forum 2016HIV Therapy in Populations with Unique Challenges – PediatricsView Video
VideoHIVGlobal HIV Clinical Forum 2016Only the Best in Botswana - Optimizing the ART Response | Ava Avalos, MDView Video
FVFrançois VenterMD, FCP, PhDVideoHIVGlobal HIV Clinical Forum 2016Optimizing HIV Therapy in Resource Limited Settings | François Venter, MD, FCP, PhDView Video
APAnton PozniakMD, FRCPVideoHIVGlobal HIV Clinical Forum 2016Integrating Science Into The Clinic: Current and Future Use of Integrase Inhibitors | Anton Pozniak, MD, FRCPView Video
PCPedro CahnMD, PhDVideoHIVGlobal HIV Clinical Forum 2016Clinical Case Discussion 1 | Pedro Cahn, MD, PhDView Video
CBCharles BoucherMD, PhDVideoHIVGlobal HIV Clinical Forum 2016Resistance Characteristics of Integrase inhibitors | Charles Boucher, MD, PhDView Video
MWMark WainbergMDVideoHIVGlobal HIV Clinical Forum 2016Basic Science of Integrase Inhibitors | Mark Wainberg, MDView Video
VideoHIVInternational Workshop on HIV & Pediatrics 2016The Challenge of Drug-Resistant TB in Children with HIV | Simon Schaaf, MMed, PhDView Video
VideoHIVInternational Workshop on HIV & Pediatrics 2016Option B+: Beyond ART – Experience with Retention and Outcomes | Landon MyerView Video
RFRashida FerrandMBBS, FRCP, MSc, PhD, FMed SciVideoHIVInternational Workshop on HIV & Pediatrics 2016It’s Not Just HIV: Complications and Research Priorities in Care of HIV-Infected Youth | Rashida Ferrand, MBBS, MRCP, MSc, DRM&HView Video
VideoHIVInternational Workshop on HIV & Pediatrics 2016Low-Resource Perspective on Adolescent Transition and Research Priorities | Mary-Ann Davies, MBChB, MMed, PhD, FCView Video
